Semaglutide is making waves as a groundbreaking treatment for insulin resistance. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist works by stimulating the pancreas to secrete more insulin and suppressing glucagon production. Furthermore, semaglutide possesses potential eff

Semaglutide has gained significant traction in recent years as a medication for treating type 2 diabetes and obesity. This potent glucagon-like peptide-1 (GLP-1) receptor agonist works by mimicking the effects of a naturally occurring hormone in the body, promoting blood sugar control . U